These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 20231775)

  • 1. Lymphatic filariasis in Andhra Pradesh Paper Mill Colony, Rajahmundry, India after nine rounds of MDA programme.
    Mukhopadhyay AK
    J Vector Borne Dis; 2010 Mar; 47(1):55-7. PubMed ID: 20231775
    [No Abstract]   [Full Text] [Related]  

  • 2. Lymphatic filariasis in Andhra Pradesh paper mill colony, Rajahmundry, after nine rounds of MDA program.
    Mukhopadhyay AK
    Indian J Public Health; 2010; 54(3):169-70. PubMed ID: 21245590
    [No Abstract]   [Full Text] [Related]  

  • 3. Coverage survey for assessing mass drug administration against lymphatic filariasis in Gulbarga district, Karnataka, India.
    Ranganath BG
    J Vector Borne Dis; 2010 Mar; 47(1):61-4. PubMed ID: 20231778
    [No Abstract]   [Full Text] [Related]  

  • 4. Knowledge on lymphatic filariasis and mass drug administration (MDA) programme in filaria endemic districts of Andhra Pradesh, India.
    Mukhopadhyay AK; Patnaik SK; Satya Babu P; Rao KN
    J Vector Borne Dis; 2008 Mar; 45(1):73-5. PubMed ID: 18399322
    [No Abstract]   [Full Text] [Related]  

  • 5. Measuring impact on filarial infection status in a community study: role of coverage of mass drug administration (MDA).
    Kumar A; Sachan P
    Trop Biomed; 2014 Jun; 31(2):225-9. PubMed ID: 25134891
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lymphatic filariasis elimination programme in Assam, India, needs change in mass drug administration strategy to target the focus of infection.
    Khan AM
    Indian J Med Res; 2018 Jan; 147(1):7-10. PubMed ID: 29749354
    [No Abstract]   [Full Text] [Related]  

  • 7. Lymphatic filariasis elimination programme in India: progress and challenges.
    Ramaiah KD
    Trends Parasitol; 2009 Jan; 25(1):7-8. PubMed ID: 19008150
    [No Abstract]   [Full Text] [Related]  

  • 8. Status of lymphatic filariasis in parts of east Godavari district of Andhra Pradesh, India.
    Mukhopadhyay AK; Patnaik SK; Babu PS
    J Vector Borne Dis; 2007 Mar; 44(1):72-4. PubMed ID: 17378221
    [No Abstract]   [Full Text] [Related]  

  • 9. Factors responsible for coverage and compliance in mass drug administration during the programme to eliminate lymphatic filariasis in the East Godavari District, South India.
    Babu BV; Satyanarayana K
    Trop Doct; 2003 Apr; 33(2):79-82. PubMed ID: 12680538
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Decline in lymphatic filariasis transmission with annual mass drug administration using DEC with and without albendazole over a 10year period in India.
    Sunish IP; Kalimuthu M; Rajendran R; Munirathinam A; Ashok Kumar V; Nagaraj J; Tyagi BK
    Parasitol Int; 2015 Feb; 64(1):1-4. PubMed ID: 25205435
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mass drug administration against lymphatic filariasis: experiences from Kozhikode district of Kerala State.
    Regu K; Showkath Ali MK; Rajendran R; Koya SM; Ganesh B; Dhariwal AC; Lal S
    J Commun Dis; 2006 Dec; 38(4):333-8. PubMed ID: 17913209
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Towards elimination of lymphatic filariasis in India.
    Das PK; Ramaiah KD; Augustin DJ; Kumar A
    Trends Parasitol; 2001 Oct; 17(10):457-60. PubMed ID: 11587940
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of mass drug administration programme on microfilaria carriers in East Godavari district of Andhra Pradesh.
    Mukhopadhyay AK; Patnaik SK
    J Vector Borne Dis; 2007 Dec; 44(4):277-80. PubMed ID: 18092536
    [No Abstract]   [Full Text] [Related]  

  • 14. Community-based study to assess the efficacy of DEC plus ALB against DEC alone on bancroftian filarial infection in endemic areas in Tamil Nadu, south India.
    Rajendran R; Sunish IP; Mani TR; Munirathinam A; Arunachalam N; Satyanarayana K; Dash AP
    Trop Med Int Health; 2006 Jun; 11(6):851-61. PubMed ID: 16772007
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Microfilaria in thyroid aspirate.
    Mohanty SK; Patnaik S; Dey P
    Diagn Cytopathol; 2002 Mar; 26(3):197-8. PubMed ID: 11892028
    [No Abstract]   [Full Text] [Related]  

  • 16. Elimination of lymphatic filariasis in India.
    Sabesan S; Ravi R; Das PK
    Lancet Infect Dis; 2005 Jan; 5(1):4-5. PubMed ID: 15620551
    [No Abstract]   [Full Text] [Related]  

  • 17. Persistence of lymphatic filarial infection in the paediatric population of rural community, after six rounds of annual mass drug administrations.
    Sunish IP; Munirathinam A; Kalimuthu M; Ashok Kumar V; Tyagi BK
    J Trop Pediatr; 2014 Jun; 60(3):245-8. PubMed ID: 24343822
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lymphatic filariasis: constraints ahead.
    Mishra CP; Singh N
    Indian J Public Health; 2003; 47(1):27-30. PubMed ID: 14723292
    [No Abstract]   [Full Text] [Related]  

  • 19. Evidence for the use of albendazole for the elimination of lymphatic filariasis.
    Sunish IP; Rajendran R; Mani TR; Dash AP; Tyagi BK
    Lancet Infect Dis; 2006 Mar; 6(3):125-6. PubMed ID: 16500593
    [No Abstract]   [Full Text] [Related]  

  • 20. A study to compare the effect of adding 12 days DEC regimen to 6 years annual mass drug administration to eliminate microfilaraemia infection in the community in rural Kanpur, Uttar Pradesh, India.
    Kumar A; Sachan P; Bajpei A; Singh T
    J Commun Dis; 2013; 45(1-2):33-40. PubMed ID: 25141552
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.